(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
4 days till quarter result
(bmo 2024-05-08)
Expected move: +/- 10.33%
Live Chart Being Loaded With Signals
TRACON Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for cancer in the United States...
Stats | |
---|---|
Dagens volum | 254 478 |
Gjennomsnittsvolum | 248 485 |
Markedsverdi | 84.64M |
EPS | $0 ( 2024-03-05 ) |
Neste inntjeningsdato | ( $-0.0600 ) 2024-05-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -16.91 |
ATR14 | $0.0190 (1.02%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-12 | Brown Scott B. | Buy | 224 800 | Employee Stock Option (Right to Buy) |
2023-04-20 | Brown Scott B. | Buy | 3 500 | Common Stock |
2024-03-12 | Theuer Charles | Buy | 518 300 | Employee Stock Option (Right to Buy) |
2023-10-20 | Theuer Charles | Buy | 3 500 | Common Stock |
2023-04-20 | Theuer Charles | Buy | 3 500 | Common Stock |
INSIDER POWER |
---|
80.91 |
Last 100 transactions |
Buy: 3 843 498 | Sell: 406 947 |
Volum Korrelasjon
TRACON Pharmaceuticals Korrelasjon
10 Mest negative korrelasjoner | |
---|---|
BNIXU | -0.898 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
TRACON Pharmaceuticals Korrelasjon - Valuta/Råvare
TRACON Pharmaceuticals Økonomi
Annual | 2023 |
Omsetning: | $12.05M |
Bruttogevinst: | $12.03M (99.88 %) |
EPS: | $-0.110 |
FY | 2023 |
Omsetning: | $12.05M |
Bruttogevinst: | $12.03M (99.88 %) |
EPS: | $-0.110 |
FY | 2022 |
Omsetning: | $0 |
Bruttogevinst: | $-16 000.00 (0.00 %) |
EPS: | $-1.400 |
FY | 2021 |
Omsetning: | $346 000 |
Bruttogevinst: | $0.00 (0.00 %) |
EPS: | $-1.660 |
Financial Reports:
No articles found.
TRACON Pharmaceuticals
TRACON Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for cancer in the United States. Its clinical stage products include envafolimab (KN035), a PD-L1 single-domain antibody for the treatment of soft tissue sarcoma; and YH001, an investigational humanized CTLA-4 IgG1 monoclonal antibody for the treatment of various cancer indications. The company's clinical stage products also include TRC102, a small molecule that is in Phase II clinical trial for the treatment of mesothelioma, and in Phase I clinical trial to treat solid tumors and lymphomas, lung cancer, and glioblastoma; and TJ004309, a CD73 antibody that is in Phase I clinical development for the treatment of solid tumors. It has collaboration and license agreements with 3D Medicines Co., Ltd. and Jiangsu Alphamab Biopharmaceuticals Co., Ltd. for the development of envafolimab; I-Mab Biopharma for the development of CD73 antibody TJ004309; Case Western Reserve University for the development of TRC102; and cooperative research and development agreement with National Cancer Institute. The company was formerly known as Lexington Pharmaceuticals, Inc. and changed its name to TRACON Pharmaceuticals, Inc. in March 2005. TRACON Pharmaceuticals, Inc. was incorporated in 2004 and is headquartered in San Diego, California.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.